- ALNY Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
-
Shorts
Alnylam Pharmaceuticals (ALNY) Short Interest
Company Profile
Filed | Period | Fund Series | #Shares | $Value | %Fund |
---|---|---|---|---|---|
28 Jan 25 | Nov 2024 | GMO Strategic Opportunities Allocation Fund | -936 | -236.87 k | -0.13 |
28 Jan 25 | Nov 2024 | GMO Implementation Fund | -16,158 | -4.09 mm | -0.18 |
28 Jan 25 | Nov 2024 | GMO Alternative Allocation Fund | -2,149 | -543.85 k | -0.31 |
28 Jan 25 | Nov 2024 | GMO Benchmark-Free Fund | -6,572 | -1.66 mm | -0.16 |
26 Dec 24 | Oct 2024 | Saba Capital Income & Opportunities Fund | -5,010 | -1.34 mm | -0.39 |
16 Dec 24 | Oct 2024 | Calamos Market Neutral Income Fund | -76,000 | -20.26 mm | -0.13 |
29 Nov 24 | Sep 2024 | TIFF Multi-Asset Fund | -4,262 | -1.17 mm | -0.09 |
25 Nov 24 | Sep 2024 | AQR Alternative Risk Premia Fund | -900 | -247.53 k | -0.11 |
25 Nov 24 | Sep 2024 | AQR Diversified Arbitrage Fund | -5,247,000 | -6.13 mm | -0.31 |
25 Nov 24 | Sep 2024 | AQR Style Premia Alternative Fund | -2,166 | -595.71 k | -0.05 |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.